Login / Signup

Hyaluronate supports hESC-cardiomyocyte cell therapy for cardiac regeneration after acute myocardial infarction.

Yuanqing TanLei WangGang ChenWenjing LiuZhongwen LiYukai WangLiu WangWei LiJun WuJie Hao
Published in: Cell proliferation (2020)
Hence, we concluded that hyaluronate-hESC-CM is a superior combination therapy for promoting cardiac regeneration after myocardial infarction.
Keyphrases
  • acute myocardial infarction
  • left ventricular
  • stem cells
  • single cell
  • cell therapy
  • percutaneous coronary intervention
  • wound healing
  • angiotensin ii
  • coronary artery disease
  • acute coronary syndrome
  • endothelial cells